
Sign up to save your podcasts
Or


Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
By John Simboli5
77 ratings
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression

3,075 Listeners

1,967 Listeners

1,093 Listeners

2,354 Listeners

948 Listeners

797 Listeners

124 Listeners

337 Listeners

6,089 Listeners

92 Listeners

10,182 Listeners

576 Listeners

149 Listeners

248 Listeners

188 Listeners